Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages

Clinical and Experimental Immunology

Volumn 145, Issue 1, 2006, Pages 155-161

  Leonard S ^a,e   Pierard, I ^a,d   Michaelsen, T E ^b   Izui, S ^c   Masson, P L ^a   Coutelier, J P ^a,d  

^a DE DUVE INSTITUTE   (Belgium)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d ICP 7430   (Belgium)

^e GlaxoSmithKline SA ^*

Author keywords

Autoantibodies; Autoimmunity; Macrophage; Phagocytosis; Total immunoglobulin

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G;

ANALYSIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL FUNCTION; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SENSITIVITY; ERYTHROPHAGOCYTOSIS; EXPERIMENTATION; FEMALE; GENETICS; IN VITRO STUDY; INHIBITION KINETICS; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PATIENT SELECTION; POLYMERIZATION; PRIORITY JOURNAL; VIRUS INFECTION;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CELLS, CULTURED; ERYTHROCYTES; FEMALE; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULINS, INTRAVENOUS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MODELS, ANIMAL; PHAGOCYTOSIS; POLYMERS; SPECIES SPECIFICITY;

EID: 33745117580     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03117.x     Document Type: Article

References (54)

1. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992 326 : 107 16.
2. Masson PL. The therapeutic use of human immunoglobulin selected on the basis of their antibody activity against circulating antigens. In : Peeters H Wright P, eds. Plasma protein pathology. Oxford : Pergamon Press, 1979 : 35 44.
3. Imbach P d'Apuzzo V Hirt A et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981 i : 1228 30.
4. Kickler T Braine HG Piantadosi S Ness PM Herman JH Rothko K. A randomized, placebo-controlled trial of intravenous gammaglobulin in alloimmunized thrombocytopenic patients. Blood 1990 75 : 313 16.
5. Newburger JW Takahashi M Burns JC et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986 315 : 341 7.
6. van der Meché FGA Schmitz PIM for the Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992 326 : 1123 9.
7. Kaveri SV Dietrich G Hurez V Kazatchkine MD. Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases. Clin Exp Immunol 1991 86 : 192 8.
8. Liblau R Gajdos P Bustarret FA el Habib R Bach J-F Morel E. Intravenous γ-globulin in myasthenia gravis: interaction with anti-acetylcholine receptor autoantibodies. J Clin Immunol 1991 11 : 128 31.
9. Masson PL. Elimination of infectious antigens and increase of IgG catabolism as possible modes of action of IVIg. J Autoimmun 1993 6 : 683 9.
10. Nydegger UE Sultan Y Kazatchkine MD. The concept of anti-idiotypic regulation of selected autoimmune diseases by intravenous immunoglobulin. Clin Immunol Immunopathol 1989 53 : S72 82.
11. Rossi F Dietrich G Kazatchkine MD. Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses. Immunol Rev 1989 110 : 135 49.
12. Rossi F Kazatchkine MD. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol 1989 143 : 4104 9.
13. Kazatchkine MD Dietrich G Hurez V et al. V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v. Ig). Immunol Rev 1994 139 : 79 107.
14. Sunblad A Marcos MAR Malanchere E et al. Observations on the mode of action of normal immunoglobulin at high doses. Immunol Rev 1994 139 : 125 58.
15. Meissner HC Schlievert PM Leung DYM. Mechanisms of immunoglobulin action: observations on Kawasaki syndrome and RSV prophylaxis. Immunol Rev 1994 139 : 109 23.
16. Abe Y Horiuchi A Miyake M Kimura S. Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy. Immunol Rev 1994 139 : 5 19.
17. Andersson U Björk L Skansén-Saphir U Andersson J. Pooled human IgG modulates cytokine production in lymphocytes and monocytes. Immunol Rev 1994 139 : 21 42.
18. Dinarello CA. Is there a role for interleukin-1 blockade in intravenous immunoglobulin therapy? Immunol Rev 1994 139 : 173 87.
19. Fridman WH Teillaud JL Amigorena S Daeron M Blank U Neauport-Sautes C. The isotypic circuit: immunoglobulins, Fc receptors and immunoglobulin binding factors. Intern Rev Immunol 1987 2 : 221 40.
20. Debré M Bonnet MC Fridman WH et al. Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet 1993 342 : 945 9.
21. Yu Z Lennon VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med 1999 340 : 227 8.
22. Hansen RJ Balthasar JP. Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia. Blood 2002 100 : 2087 93.
23. Bruhns P Samuelsson A Pollard JW Ravetch JV. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 2003 18 : 573 81.
24. Teeling JL Jansen-Hendriks T Kuijpers TW et al. Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia. Blood 2001 98 : 1095 9.
25. Fehr J Hofmann V Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 1982 306 : 1254 8.
26. Kimberly RP Salmon JE Bussel JB Kuntz Crow M Hilgartner MW. Modulation of mononuclear phagocyte function by intravenous γ-globulin. J Immunol 1984 132 : 745 50.
27. Oksenhendler E Bierling P Brossard Y et al. Anti-RH immunoglobulin therapy for human immunodeficiency virus-related immune thrombocytopenic purpura. Blood 1988 71 : 1499 502.
28. Clarkson SB Bussel JB Kimberly RP Valinsky JE Nachman RL Unkeless JC. Treatment of refractory immune thrombocytopenic purpura with an anti-Fcγ-receptor antibody. N Engl J Med 1986 314 : 1236 9.
29. Salama A Mueller-Eckhardt C Kiefel V. Effect of intravenous immunoglobulin in immune thrombocytopenia. Competitive inhibition of reticuloendothelial system function by sequestration of autologous red blood cells? Lancet 1983 ii : 193 5.
30. Bussel JB Cunningham-Rundles C Abraham C. Intravenous treatment of autoimmune hemolytic anemia with very high dose gammaglobulin. Vox Sang 1986 51 : 264 9.
31. Besa EC. Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. Am J Med 1988 84 : 691 8.
32. Samuelsson A Towers TL Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001 291 : 484 6.
33. Crow AR Song S Freedman J et al. IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity. Blood 2003 102 : 558 60.
34. Reininger L Shibata T Ozaki S Shirai T Jaton J-C Izui S. Variable region sequences of pathogenic anti-mouse red blood cell autoantibodies from autoimmune NZB mice. Eur J Immunol 1990 20 : 771 7.
35. Shibata T Berney T Reininger L et al. Monoclonal anti-erythrocyte autoantibodies derived from NZB mice cause autoimmune hemolytic anemia by two distinct pathogenic mechanisms. Intern Immunol 1990 2 : 1133 41.
36. Pottier Y Pierard I Barclay A Masson PL Coutelier J-P. The mode of action of treatment by IgG of haemolytic anaemia induced by an anti-erythrocyte monoclonal antibody. Clin Exp Immunol 1996 106 : 103 7.
37. Coutelier JP Van Snick J. Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. Eur J Immunol 1985 15 : 250 5.
38. Michaelsen TE Natvig JB. Characterization of subclass-related F(ab) 2, Fab/c and Fch fragments obtained by short papain digestion of human IgG myeloma proteins. Scand J Immunol 1973 2 : 299 312.
39. Natvig JB Kunkel HG. Human immunoglobulins: classes, subclasses, genetic variants, and idiotypes. Adv Immunol 1973 16 : 1 59.
40. Meite M Léonard S El Azami El Idrissi M Izui S Masson PL Coutelier J-P. Exacerbation of autoantibody-mediated hemolytic anemia by viral infection. J Virol 2000 74 : 6045 9.
41. Jefferis R Lund J. Interaction sites on human IgG-Fc for FcγR: current models. Immunol Lett 2002 82 : 57 65.
42. Meyer D Schiller C Westermann J et al. FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood 1998 92 : 3997 4002.
43. Segal DM Dower SK Titus JA. The FcR-mediated endocytosis of model immune complexes by cells from the P388D1 mouse macrophage line. I. Internalization of small, nonaggregating oligomers of IgG. J Immunol 1983 130 : 130 7.
44. Bazin R Lemieux R Tremblay T St-Amour I. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells. Br J Haematol 2004 127 : 90 6.
45. Kurlander RJ Gartrell JE. The binding and processing of monoclonal human IgG1 by cells of a human macrophage-like cell line (U937). Blood 1983 62 : 652 62.
46. Segal DM Titus JA Dower SK. The FcR-mediated endocytosis of model immune complexes by cells from the P388D1 mouse macrophage line. II. The role of ligand-induced self-aggregation in promoting internalization. J Immunol 1983 130 : 138 44.
47. Roux KH Strelets L Michaelsen TE. Flexibility of human IgG subclasses. J Immunol 1997 159 : 3372 82.
48. Roux KH Tankersley DL. A view of the human idiotypic repertoire. Electron microscopic and immunologic analyses of spontaneous idiotype-anti-idiotype dimers in pooled human IgG. J Immunol 1990 144 : 1387 95.
49. Gavin AL Leiter EH Hogarth PM Mouse Fcγ RI. identification and functional characterization of five new alleles. Immunogenetics 2000 51 : 206 11.
50. Parren PWHI Warmerdam PAM Boeije LCM et al. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J Clin Invest 1992 90 : 1537 46.
51. Bredius RGM de Vries CEE Troelstra A et al. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFcγRIIa polymorphism to IgG2. J Immunol 1993 151 : 1463 72.
52. Musaji A Cormont F Thirion G Cambiaso CL Coutelier J-P. Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses. Blood 2004 104 : 2102 6.
53. Musaji A Meite M Detalle L et al. Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia. Autoimmun Rev 2005 4 : 247 52.
54. Fossati-Jimack L Ioan-Facsinay A Reininger L et al. Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcγ receptor III. J Exp Med 2000 191 : 1293 302.